Provided by Tiger Trade Technology Pte. Ltd.

Sutro Biopharma Inc

23.50
-0.0750-0.32%
Post-market: 23.500.00000.00%18:16 EDT
Volume:467.58K
Turnover:11.34M
Market Cap:389.25M
PE:-0.91
High:26.34
Open:24.38
Low:23.05
Close:23.57
52wk High:26.54
52wk Low:5.23
Shares:16.57M
Float Shares:15.15M
Volume Ratio:1.48
T/O Rate:3.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-25.8759
EPS(LYR):-29.6061
ROE:-1810.01%
ROA:-25.80%
PB:-4.46
PE(LYR):-0.79

Loading ...

Aug 31, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 08, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 26, 2022

Major Issues Report

8-K - Current report
Jul 08, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 28, 2022

Major Issues Report

8-K - Current report
Jun 16, 2022

Major Issues Report

8-K - Current report
Jun 07, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 20, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 18, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Jan 05, 2022

Major Issues Report

8-K - Current report